Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | Diphenyl chlorophosphate | HCID 75654 | — |
| Reactant | HCID 10848153 | HCID 10848153 | — |
| Reactant | HCID 22405058 | HCID 22405058 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 22405086 | HCID 22405086 | 77.5% |
Reaction Steps
To a solution of 3-chloro-4-[2-(2-methylphenyl)benzoylamino]benzoic acid (309 mg), diphenyl chlorophosphate (251 mg), 1-ethoxycarbonylmethyl-1,3,4,5-tetrahydro-1,5-benzodiazepin-2(2H)-one (210 mg) in tetrahydrofuran (15 ml) was added triethylamine (172 mg) at 0° C. The resulting mixture was allowed to warm to ambient temperature where it was maintained for 5 hours. The solvent was evaporated and diluted with ethyl acetate and washed with water, diluted hydrochloric acid, saturated sodium bicarbonate aqueous solution and brine. The organic layer was dried over magnesium sulfate and concentrated to give 5-{3-chloro-4-[2-(2-methylphenyl)benzoylamino]benzoyl}-1-ethoxycarbonylmethyl-1,3,4,5-tetrahydro-1,5-benzodiazepin-2(2H)-one (390 mg) which was purified by recrystallization from a mixture of ethyl acetate and n-hexane.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05521170 |
|---|
| Source dataset | uspto-grants-1996_05 |
|---|
| ORD ID | ord-59de664324284b98ac9b3a643a21c439 |
|---|
| Source note | uspto-grants-1996_05 |
|---|